A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Repligen Corp stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 17,500 shares of RGEN stock, worth $2.44 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,500
Holding current value
$2.44 Million
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$120.0 - $182.95 $2.1 Million - $3.2 Million
17,500 New
17,500 $2.21 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.74B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Portfolio

Follow Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund), based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) with notifications on news.